Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118224) titled 'RNA editome analysis of Parkinson's disease and its role in disease progression' on Feb. 3.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Quzhou People's Hospital
Condition:
Parkinson's Disease (PD)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-15
Target Sample Size: Parkinson's group and non-Parkinson's group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=306797
Disclaimer: Curated by HT Syndication....